Nanalysis to Present at the LD Micro Main Event XVII
Presentation at 3:00 PM PT/6:00 PM ET on Wednesday, October 30th
CALGARY, AB, Oct. 15, 2024 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications announces that Chief Executive Officer Sean Krakiwsky will be presenting at the 17th annual Main Event on Wednesday, October 30th at 3:00PM PT at the Luxe Sunset Boulevard Hotel.
Event: LD Micro Main Event XVII
Date: Wednesday, October 30th
Time: 3:00 PM PT/6:00PM ET
Register to watch the virtual presentation here: LD Micro Main Event XVII 2024 | Sequire Events
Summary of LD Micro Main Event XVII
The 2024 LD Micro Main Event XVII will run from October 28th to the 30th at the Luxe Sunset Boulevard Hotel in Los Angeles.
Registration will begin at 3:00 PM PT on the 28th followed by keynotes and happy hour.
Presentations will run from 8:00 AM PT - 5:00 PM PT on the 29th and 30th.
This three-day event will feature around 150 companies, presenting in half-hour increments, and attending private meetings with investors.
About Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA:1N1)
Nanalysis Scientific Corp. operates two primary business segments: Scientific Equipment and Security Services. Within its Scientific Equipment business is what the Company terms "MRI and NMR for industry". The Company develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60™ was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The Company has followed up that initial offering with new products and continues to have a strong innovation pipeline. In 2020, the Company announced the launch of its 100MHz device, the most powerful and most advanced compact NMR device ever brought to market.
The Company's devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The Company continues to exploit new global market opportunities independently and with partners. With its partners, the Company provides scientific equipment sales and maintenance services globally.
In 2022 the Company was awarded a five-year, $160 million contract to provide maintenance services for passenger screening equipment in Canadian airports. This has resulted in expansion of the Company's Security Services business. The Company is providing airport security equipment maintenance services in each province and territory of Canada. In addition, the Company provides commercial security equipment installation and maintenance services to a variety of customers in North America.
About LD Micro
LD Micro, a wholly owned subsidiary of Freedom US Markets, was founded in 2006 with the sole purpose of being an independent resource in the micro-cap space. Through the LD Micro Index and annual investor conferences, LD has served as an invaluable asset to all those interested in discovering the next generation of great companies. For more information on LD Micro, visit www.ldmicro.com.
To present or register, please contact registration@ldmicro.com.
Notice regarding Forward Looking Statements and Legal Disclaimer
This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
View original content:https://www.prnewswire.com/news-releases/nanalysis-to-present-at-the-ld-micro-main-event-xvii-302276025.html
SOURCE Nanalysis Scientific Corp.
Upcoming Life Sciences Events
- January 2025
- San Francisco: 8th Annual Neuroscience Innovation Forum
- San Francisco: RESI JPM 2025
- San Francisco: Biotech Showcase™
Latest company news
Rakovina Therapeutics Announces Closing of Oversubscribed $3M Private Placement